Press Release Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Press Release REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Press Release Ituran Selected to Provide Full Connectivity Solution for Fiat Connect in South America
Press Release Sustainability Report 2024: ENNOVI Earns EcoVadis Platinum, CDP Recognition and Gold Asia Sustainability Award
